Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 4th October 2013
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FEI announces changes to Equine Prohibited Substances List
FEI Bureau has approved the changes proposed by the FEI List Group

The Fédération Equestre Internationale (FEI) Bureau has approved changes to the Equine Prohibited Substances List proposed by its List Group. The new prohibited substances list will come into effect on January 1, 2014.

Previously unlisted Metformin, a potent but legitimate oral anti-diabetic drug with a potential welfare risk, has been added to the Controlled Medication list.

Levothyroxine, an exogenous thyroid hormone replacement that could enhance performance, has also been added to the Controlled Medication list after having been unlisted.

Adrenocortico-trophic hormone (ACTH) will be moved from Banned Substances to the Controlled Medication section for the 2014 list, due to its therapeutic value in equine medicine.

Three previously unlisted substances will be added to the Banned Substances section of the 2014 list .

Ammonium Chloride injectable, Gamma Butyrolactone (GBL) and Gamma-Hydroxybutyrate (GHB) are considered to have the potential for abuse to improve athletic performance.

The approved changes to the list are also accessible on the FEI Clean Sport webpage.

The FEI Equine Prohibited Substances Database will be amended and the complete 2014 list will be made available on the Clean Sport website prior to January 1, 2014.

Conforming with FEI rules, all changes to the list are published 90 days prior to implementation to allow National Federations, athletes and veterinarians sufficient time to familiarise themselves with the revised list.

 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.